CIK: 0001839948 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $3,021,699 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,622,151 | $72,475 | 2.4% | $13.48 | 0.0% | COMM | 61225M102 |
| BHVN | BIOHAVEN LTD | 4,631,317 | $52,288 | 1.7% | $12.39 | 0.0% | COMM | G1110E107 |
| IMVT | IMMUNOVANT INC | 1,660,933 | $42,221 | 1.4% | $22.30 | 0.0% | COMM | 45258J102 |
| JANX | JANUX THERAPEUTICS INC | 1,789,617 | $24,697 | 0.8% | $23.52 | 0.0% | COMM | 47103J105 |
| ALEC | ALECTOR INC | 10,000,000 | $15,600 | 0.5% | $1.77 | 0.0% | COMM | 014442107 |
| MAZE | MAZE THERAPEUTICS INC | 173,816 | $7,201 | 0.2% | $34.37 | 0.0% | COMM | 578784100 |
| MIRM | MIRUM PHARMACEUTICALS INC | 62,049 | $4,901 | 0.2% | $71.78 | 0.0% | COMM | 604749101 |
| LONA | Athira Pharma, Inc. | 464,398 | $3,349 | 0.1% | $4.58 | 0.0% | COMM | 04746L203 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT THERAPEUTICS INC | 2,582,408 (+57.8%) | $87,466 (+107.3%) | 2.9% | $16.21 | +91.6% | COMM | 75382E208 |
| SYRE | SPYRE THERAPEUTICS INC | 1,900,582 (+72.7%) | $62,263 (+237.5%) | 2.1% | $20.44 | +27.8% | COMM | 00773J202 |
| TNGX | TANGO THERAPEUTICS INC | 12,762,094 (+49.5%) | $113,072 (+57.7%) | 3.7% | $5.96 | +44.6% | COMM | 87583X109 |
| ADCT | ADC THERAPEUTICS SA | 11,390,175 (+719.3%) | $40,207 (+623.1%) | 1.3% | $3.95 | +2.8% | COMM | H0036K147 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 4,286,480 (+36.7%) | $107,205 (+40.9%) | 3.5% | $12.97 | — | ADRS | 152309100 |
| KOD | KODIAK SCIENCES INC | 1,445,538 (+26.2%) | $40,417 (+115.5%) | 1.3% | $7.55 | +171.3% | COMM | 50015M109 |
| TRDA | ENTRADA THERAPEUTICS INC | 2,088,392 (+257.0%) | $21,469 (+532.8%) | 0.7% | $12.20 | — | COMM | 29384C108 |
| ARVN | ARVINAS HOLDING CO LLC | 2,666,216 (+64.8%) | $31,621 (+129.5%) | 1.0% | $8.90 | +22.7% | COMM | 04335A105 |
| RLAY | RELAY THERAPEUTICS INC | 3,220,186 (+77.9%) | $27,243 (+188.3%) | 0.9% | $5.27 | +35.5% | COMM | 75943R102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TOURMALINE BIO INC | 1,311,783 | $62,743 | 2.1% | $25.14 | — | — | 89157D105 |
| IRON | DISC MEDICINE INC | 465,257 | $30,744 | 1.0% | $33.98 | +148.7% | — | 254604101 |
| — | ASTRIA THERAPEUTICS INC | 2,761,861 | $20,106 | 0.7% | $14.07 | — | — | 04635X102 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,668,174 | $7,557 | 0.3% | $7.02 | — | — | 00773U207 |
| PEPG | PEPGEN INC | 1,200,000 | $5,544 | 0.2% | $1.61 | +222.0% | — | 713317105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 5,868,162 (-13.7%) | $208,437 (+113.5%) | 6.9% | $9.05 | +210.6% | COMM | 19240Q201 |
| GPCR | STRUCTURE THERAPEUTICS INC | 920,857 (-13.4%) | $64,046 (+115.2%) | 2.1% | $43.45 | — | ADRS | 86366E106 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,181,841 (-17.4%) | $32,170 (-44.0%) | 1.1% | $34.05 | +3.0% | COMM | 00847X104 |
| UPB | UPSTREAM BIO INC | 743,886 (-64.9%) | $20,197 (-49.3%) | 0.7% | $22.33 | +11.5% | COMM | 91678A107 |
| MNPR | MONOPAR THERAPEUTICS INC | 141,915 (-7.2%) | $9,267 (-25.8%) | 0.3% | $44.70 | +82.8% | COMM | 61023L207 |
| OCUL | OCULAR THERAPEUTIX INC | 5,740,231 (-6.2%) | $69,686 (-2.6%) | 2.3% | $7.73 | +57.1% | COMM | 67576A100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 7,111,596 | $959,034 | 31.7% | $23.46 | — | ADRS | 00370M103 |
| TYRA | TYRA BIOSCIENCES INC | 2,898,103 | $76,191 | 2.5% | $12.78 | +43.7% | COMM | 90240B106 |
| DYN | DYNE THERAPEUTICS INC | 4,615,144 | $90,272 | 3.0% | $14.30 | +32.4% | COMM | 26818M108 |
| SVRA | SAVARA INC | 12,362,205 | $74,544 | 2.5% | $3.73 | +31.2% | COMM | 805111101 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 1,710,084 | $58,981 | 2.0% | $21.69 | +31.2% | COMM | 53635D202 |
| KRRO | KORRO BIO INC | 416,301 | $3,335 | 0.1% | $22.19 | +5.3% | COMM | 500946108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 3,572,335 | $65,267 | 2.2% | $10.51 | +34.8% | COMM | 30233G209 |
| RVMD | REVOLUTION MEDICINES INC | 436,473 | $34,765 | 1.2% | $39.15 | +67.5% | COMM | 76155X100 |
| LBRX | LB PHARMACEUTICALS INC | 1,745,015 | $38,844 | 1.3% | $15.87 | +10.1% | COMM | 50180M108 |
| FULC | FULCRUM THERAPEUTICS INC | 5,250,000 | $59,378 | 2.0% | $7.42 | +37.2% | COMM | 359616109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 6,243,812 | $75,425 | 2.5% | $2.86 | +374.1% | COMM | 03237H101 |
| MBX | MBX BIOSCIENCES INC | 650,000 | $20,501 | 0.7% | $22.87 | +6.1% | COMM | 55287L101 |
| XNCR | XENCOR INC | 2,452,138 | $37,542 | 1.2% | $18.82 | -20.6% | COMM | 98401F105 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,676,580 | $1,772 | 0.1% | $3.41 | +5.9% | COMM | 92840H400 |
| CGON | CG ONCOLOGY INC | 3,670,206 | $152,387 | 5.0% | $40.67 | +1.7% | COMM | 156944100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,676,624 | $69,094 | 2.3% | $25.70 | +50.9% | COMM | 252828108 |
| SLN | SILENCE THERAPEUTICS PLC | 3,033,560 | $18,444 | 0.6% | $14.21 | — | ADRS | 82686Q101 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $8,771 | 0.3% | $10.31 | +63.7% | COMM | 05338F306 |
| URGN | UROGEN PHARMA LTD | 717,347 | $16,800 | 0.6% | $17.96 | +20.8% | COMM | M96088105 |
| VTYX | VENTYX BIOSCIENCES INC | 316,195 | $2,855 | 0.1% | $29.94 | -75.0% | COMM | 92332V107 |